Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(20%)
Results Posted
75%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
5
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Withdrawn2
Active, not recruiting1
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

active_not_recruiting110%
completed440%
recruiting110%
withdrawn220%
unknown110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
10